AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 279: E235-E243, 2000;
0193-1849/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donmoyer, C. M.
Right arrow Articles by McGuinness, O. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donmoyer, C. M.
Right arrow Articles by McGuinness, O. P.
Vol. 279, Issue 2, E235-E243, August 2000

Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN

Christine M. Donmoyer, Sheng-Song Chen, Scott A. Hande, D. Brooks Lacy, Joseph Ejiofor, and Owen P. McGuinness

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

In animals receiving total parenteral nutrition (TPN), infection impairs net hepatic glucose uptake (NHGU) by 40% and induces mild hyperinsulinemia. In the normal animal, the majority of the glucose taken up by the liver is diverted to lactate, but in the infected state, lactate release is curtailed. Because of the hyperinsulinemia and reduced NHGU, more glucose is utilized by peripheral tissues. Our aims were to determine the role of infection-induced hyperinsulinemia in 1) limiting the fall in NHGU and hepatic lactate release and 2) increasing the proportion of glucose disposed of by peripheral tissues. Chronically catheterized dogs received TPN for 5 days via the inferior vena cava. On day 3, a fibrin clot with a nonlethal dose of E. coli was placed into the peritoneal cavity; sham dogs received a sterile clot. On day 5, somatostatin was infused to prevent endogenous pancreatic hormone secretion, and insulin and glucagon were replaced at rates matching incoming hormone concentrations observed previously in sham or infected dogs. The TPN-derived glucose infusion was adjusted to maintain a constant arterial plasma glucose level of ~120 mg/dl. after a basal blood sampling period, the insulin infusion rate was either maintained constant (infected time control, Hi-Ins, n = 6; sham time control, Sham, n = 6) or decreased (infected + reduced insulin, Lo-Ins; n = 6) for 180 min to levels seen in noninfected dogs (from 23 ± 2 to 12 ± 1 µU/ml). Reduction of insulin to noninfected levels decreased NHGU by 1.4 ± 0.5 mg · kg-1 · min-1 (P < 0.05) and nonhepatic glucose utilization by 4.8 ± 0.8 mg · kg-1 · min-1 (P < 0.01). The fall in NHGU was caused by a decline in HGU (Delta -0.6 ± 0.4 mg · kg-1 · min-1) and a concomitant increase in hepatic glucose production (HGP, Delta 0.8 ± 0.5 mg · kg-1 · min-1); net hepatic lactate release was not altered. Hyperinsulinemia that accompanies infection 1) primarily diverts glucose carbon to peripheral tissues, 2) limits the fall in NHGU by enhancing HGU and suppressing HGP, and 3) does not enhance hepatic lactate release, thus favoring hepatic glucose storage. Compensatory hyperinsulinemia plays a critical role in facilitating hepatic and peripheral glucose disposal during an infection.

total parenteral nutrition; liver; glucose; lactate; dog


This article has been cited by other articles:


Home page
DiabetesHome page
D. S. Edgerton, A. D. Cherrington, P. Williams, D. W. Neal, M. Scott, L. Bowen, W. Wilson, C. H. Hobbs, C. Leach, M.-c. Kuo, et al.
Inhalation of Human Insulin (Exubera) Augments the Efficiency of Muscle Glucose Uptake In Vivo
Diabetes, December 1, 2006; 55(12): 3604 - 3610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S.-S. Chen, C. M. Donmoyer, D. A. Pearson, A. Poole, Y. Zhang, D. B. Lacy, and O. P. McGuinness
Impact of infection on glucose-dependent liver glucose uptake during TPN: interaction with insulin
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E286 - E295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Donmoyer, S.-S. Chen, D. B. Lacy, D. A. Pearson, A. Poole, Y. Zhang, and O. P. McGuinness
Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E574 - E582.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Donmoyer, D. B. Lacy, Y. Zhang, S.-S. Chen, and O. P. McGuinness
Impact of chronic fructose infusion on hepatic metabolism during TPN administration
Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1151 - E1158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Donmoyer, J. Ejiofor, D. B. Lacy, S.-S. Chen, and O. P. McGuinness
Fructose augments infection-impaired net hepatic glucose uptake during TPN administration
Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E703 - E711.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online